NCT00384072

Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 500 (estimated)
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: Female
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the effect of 20 mg of bazedoxifene in comparison to placebo on bone mineral density after 6 months of therapy in a population of postmenopausal Asian women.

Conditions

• Postmenopause
• Osteoporosis

Interventions

Type	Name	Description
DRUG	bazedoxifene BZA-20

Timeline

• Start date: 2006-05-01
• Completion: 2007-09-01
• First posted: 2006-10-04
• Last updated: 2007-12-28

Locations

20 sites across 3 countries: China, South Korea, Taiwan